Provided by Tiger Fintech (Singapore) Pte. Ltd.

Opthea Limited

0.4400
+0.0000
Volume:- -
Turnover:- -
Market Cap:541.68M
PE:-1.67
High:0.4400
Open:0.4400
Low:0.4400
Close:0.4400
Loading ...

Opthea Limited (CKDXF) was downgraded to a Sell Rating at Bell Potter

TIPRANKS
·
02 Apr

Analysts Offer Insights on Healthcare Companies: Opthea Limited (OtherCKDXF), Outset Medical (OM) and Maravai Lifesciences Holdings (MRVI)

TIPRANKS
·
26 Mar

Opthea Limited: Hold Rating Amid Phase 3 Trial Failure and Financial Uncertainty

TIPRANKS
·
25 Mar

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Opthea Limited Sponsored ADR (OPT) and Larimar Therapeutics (LRMR)

TIPRANKS
·
25 Mar

Opthea Limited Suspends Trading Pending Clinical Trial Results

TIPRANKS
·
19 Mar

JPMorgan Acquires Substantial Stake in Opthea Limited

TIPRANKS
·
14 Mar

Opthea Limited Announces Quotation of New Securities on ASX

TIPRANKS
·
14 Mar

Opthea Limited Announces New Securities Quotation on ASX

TIPRANKS
·
11 Mar

Opthea Limited: Promising Clinical Trials and Strong Financial Position Support Buy Rating with $13 Target

TIPRANKS
·
03 Mar

Opthea Limited Reports Increased Losses Amid Clinical Advancements

TIPRANKS
·
03 Mar

Opthea Limited Reports Increased Loss Amid Clinical Progress

TIPRANKS
·
03 Mar

Opthea Limited Reports Strong Financial Position and Progress in Wet AMD Treatment Trials

TIPRANKS
·
28 Feb

Opthea Limited Releases Half-Year Financial Report for 2024

TIPRANKS
·
28 Feb

Opthea Limited Announces New Securities Quotation on ASX

TIPRANKS
·
21 Feb

Wilsons upgrades Opthea Limited (CKDXF) to a Hold

TIPRANKS
·
20 Feb

Optimistic Outlook and Buy Rating for Opthea Limited Amid Promising Phase 3 Trials and Strong Financial Position

TIPRANKS
·
18 Feb

Opthea Limited Announces New Securities Quotation on ASX

TIPRANKS
·
17 Feb

Is Opthea Limited (OPT) the Best Long Term ASX Stock to Buy Now?

Insider Monkey
·
12 Feb

Opthea Limited Announces Cessation of 3 Million Securities

TIPRANKS
·
11 Feb

Opthea Limited Announces Quotation of New Securities

TIPRANKS
·
11 Feb